Trials / Terminated
TerminatedNCT00947674
A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)
Prospective, Randomized, Double-Blind, Sham Treatment Controlled Multicenter Study to Evaluate Efficacy and Safety of Cellsorba™EX Used for Leukocytapheresis (LCAP) in Patients With Steroid-Free, Active Ulcerative Colitis
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Asahi Kasei Medical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, randomized, double-blind, sham treatment controlled multicenter study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cellsorba EX | conduct treatment twice a week for 3 weeks and once a week for 4 weeks, total 10 times |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2012-01-01
- Completion
- 2012-10-01
- First posted
- 2009-07-28
- Last updated
- 2012-12-06
Locations
10 sites across 6 countries: Czechia, Germany, Israel, Japan, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00947674. Inclusion in this directory is not an endorsement.